Authors:
Fournes, B
Sadekova, S
Turbide, C
Letourneau, S
Beauchemin, N
Citation: B. Fournes et al., The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity, ONCOGENE, 20(2), 2001, pp. 219-230
Authors:
Blau, DM
Turbide, C
Tremblay, M
Olson, M
Letourneau, S
Michaliszyn, E
Jothy, S
Holmes, KV
Beauchemin, N
Citation: Dm. Blau et al., Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection, J VIROLOGY, 75(17), 2001, pp. 8173-8186
Authors:
Sadekova, S
Lamarche-Vane, N
Li, XD
Beauchemin, N
Citation: S. Sadekova et al., The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of rho-like GTPases, MOL BIOL CE, 11(1), 2000, pp. 65-77
Authors:
Izzi, L
Turbide, C
Houde, C
Kunath, T
Beauchemin, N
Citation: L. Izzi et al., cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function, ONCOGENE, 18(40), 1999, pp. 5563-5572
Authors:
Huber, M
Izzi, L
Grondin, P
Houde, C
Kunath, T
Veillette, A
Beauchemin, N
Citation: M. Huber et al., The carboxyl-terminal region of biliary glycoprotein controls its tyrosinephosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells, J BIOL CHEM, 274(1), 1999, pp. 335-344
Authors:
Beauchemin, N
Draber, P
Dveksler, G
Gold, P
Gray-Owen, S
Grunert, F
Hammarstrom, S
Holmes, KV
Karlsson, A
Kuroki, M
Lin, SH
Lucka, L
Najjar, SM
Neumaier, M
Obrink, B
Shively, JE
Skubitz, KM
Stanners, CP
Thomas, P
Thompson, JA
Virji, M
von Kleist, S
Wagener, C
Watt, S
Zimmermann, W
Citation: N. Beauchemin et al., Redefined nomenclature for members of the carcinoembryonic antigen family, EXP CELL RE, 252(2), 1999, pp. 243-249
Authors:
Robitaille, J
Izzi, L
Daniels, E
Zelus, B
Holmes, KV
Beauchemin, N
Citation: J. Robitaille et al., Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bgp1 and Bgp2, EUR J BIOCH, 264(2), 1999, pp. 534-544